Clinical Factors Contributing Readmission in 28 days Due to Acute Exacerbation in COPD Patients in Somdetphraphutthaloetla Hospital
Keywords:
Chronic obstructive pulmonary disease, acute exacerbation, readmissionAbstract
Objectives: The purpose of this study was to describe the clinical characteristics of COPD patients, treatment outcomes and clinical factors contributing the acute exacerbation resulting in readmission within 28 days.
Methods: This is a retrospective, descriptive study of COPD patients who were readmitted within 28 days due to acute exacerbation at Somdetphraphutthaloetla Hospital during 1 January 2017 to 31 December 2018. Statistic analysis was used to identify patients characteristics, treatment outcomes and clinical factors.
Results: The hospitalized COPD patients with acute exacerbation in this study were 88 cases. The mean age was 71.89 years, 74 males and 14 females. For smoking, 44 were ex-smokers whereas 24 were current smokers. The most comorbidity was hypertension(38.63%). The most severity was GOLD stage 3 (56.82%). The most important contributing factors for acute exacerbation was pneumonia 31.82% in first admission and 47.72% (p =0.031) in readmission. The most common causative organism was Klebsiella pneumoniae(28.57%) in first admission and Acinetobacter baumannii (23.81%, p=0.036) in readmission. The length of symptom was averagely 2.5 days in first admission and 1.8 days in readmission (p=0.001). The hospital stay day was averagely 6 days in first admission and 7.6 days in readmission. Six patients in readmission group were dead (6.82%).
Conclusions: Pneumonia was the important contributing factor for acute exacerbation leading to readmission within 28 days resulting in increased morbidity and mortality in COPD patients
References
2. Viniol C, Vogelmeier CF. Exacerbations of COPD. Eur Respir Rev. 2018; 27(147). pii: 170103. doi: 10.1183/16000617.0103-2017.
3. Ko FW, Chan KP, Hui DS. Acute exacerbation of COPD. Respiratory. 2016; 21(7): 1152-65.
4. Guerrero M, Crisafulli E, Liapikou A, et al. Readmission for acute exacerbation within 30 days of discharge is associated with a subsequent progressive increase in mortality risk in COPD patients : a long-term observational study. PLoS One. 2016; 11(3): e0150737.
5. Burge S, Wedzich JA. COPD exacerbations: definitions and classifications. Eur Respir J. 2003; 21: Suppl.41: 46s–53s.
6. Butorac-Petanjek B, Parnham MJ, Popovic-Grle S. Antibiotic therapy for exacerbations of chronic obstructive pulmonary disease (COPD). J Chemotherapy. 2010; 22(5): 291-7.
7. Siddiqi A, Sethi S. Optimizing antibiotic selection in treating COPD exacerbations. Int J Chron Obstruct Pulmon Dis. 2008; 3(1): 31–44.
8. Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2019. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease [internet]. 2019. [cited 2019 May 18]. Available from:http://www.goldcopd.org/.
9. Lode H, Allewelt M, Balk S, et al. A Prediction model for bacterial etiology in acute exacerbations of COPD. Infection. 2007; 35(3): 143–9.
10. Shah T, Press VG, Huisingh-Scheetz M, et al. COPD readmissions: Addressing COPD in the era of value-based health. Chest. 2016; 150(4): 916-26.
11. Hunter LC, Lee RJ, Butcher I, et al. Patient characteristics associated with risk of first hospital admission and readmission for acute exacerbation of chronic obstructive pulmonary disease (COPD) following primary care COPD diagnosis: a cohort study using linked electronic patient records. BMJ Open. 2016; 6(1): e009121.
12. Lau SMC, Siracuse BL, Chamberlain RS. Readmission after COPD exacerbation scale: determining 30-day readmission risk for COPD patients. International Journal of COPD. 2017; 12: 1891–902.
13. Ramon Boixeda, Sandra Bacca, Lorena Elias, et al. Pneumonia as comorbidity in chronic obstructive pulmonary disease (COPD). Differences between Acute exacerbation of COPD and pneumonia in patients with COPD. Arch Bronconeumol. 2014; 50(12): 514–20.
14. Halpin DM, Miravitlles M, Metzdorf N, et al. Impact and prevention of severe exacerbations of COPD: a review of the evidence. International Journal of COPD. 2017; 12: 2891–908.
Downloads
Published
How to Cite
Issue
Section
License
ลิขสิทธิ์บทความเป็นของผู้เขียนบทความ แต่หากผลงานของท่านได้รับการพิจารณาตีพิมพ์ลงวารสารแพทย์เขต 4-5 จะคงไว้ซึ่งสิทธิ์ในการตีพิมพ์ครั้งแรกด้วยเหตุที่บทความจะปรากฎในวารสารที่เข้าถึงได้ จึงอนุญาตให้นำบทความในวารสารไปใช้ประโยชน์ได้ในเชิงวิชาการโดยจำเป็นต้องมีการอ้างอิงถึงชื่อวารสารอย่างถูกต้อง แต่ไม่อนุญาตให้นำไปใช้ในเชิงพาณิชย์
